Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient
  • Published Date:

    Sep 2012

  • Source:
    Emerg Infect Dis. 18(9):1493-1495.
Filetype[PDF-208.23 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 146.98 KB]
    Personal Author:
    Conroy, Niall; Vlack, Susan; Williams, Julian M.; Patten, John J.; Horvath, Robert L.; Lambert, Stephen B.;
    Published Date:
    Feb 28 2013
    Source:
    PLoS Negl Trop Dis. 2013; 7(2).
    Description:
    BackgroundAustralia uses a protocol combining human rabies immunoglobulin (HRIG) and rabies vaccine for post-exposure prophylaxis (PEP) of rabies and Australian bat lyssavirus (ABLV), with the aim of achieving an antibody titre of ≥0.5 IU/ml, as pe...
    File Type:
    Filetype[PDF - 146.98 KB]
  2. Filetype[PDF - 212.90 KB]
    Personal Author:
    Li, Anyie J.; Sreenivasan, Nandini; Siddiqi, Umme Ruman; Tahmina, Sanya; Penjor, Kinley; Sovann, Ly; Gunesekera, Amila; Blanton, Jesse D.; Knopf, Lea; Hyde, Terri B.;
    Published Date:
    October 09 2018
    Source:
    Vaccine.
    Description:
    Background:There are approximately 35,000 human deaths from rabies in Asia annually. Rabies can be prevented through timely post-exposure prophylaxis (PEP) consisting of wound washing, rabies vaccine, and in some cases, rabies immunoglobulin (RIG). H...
    File Type:
    Filetype[PDF - 212.90 KB]
  3. Filetype[PDF - 190.37 KB]
    Personal Author:
    Murphy, Julia; Sifri, Costi D.; Pruitt, Rhonda; Hornberger, Marcia; Bonds, Denise; Blanton, Jesse; Ellison, James; Cagnina, R. Elaine; Enfield, Kyle B.; Shiferaw, Miriam; Gigante, Crystal; Condori, Edgar; Gruszynski, Karen; Wallace, Ryan M.;
    Published Date:
    Jan 04 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 67(5152):1410-1414
    Description:
    On May 9, 2017, the Virginia Department of Health was notified regarding a patient with suspected rabies. The patient had sustained a dog bite 6 weeks before symptom onset while traveling in India. On May 11, CDC confirmed that the patient was infect...
    File Type:
    Filetype[PDF - 190.37 KB]
  4. Filetype[PDF - 115.45 KB]
    Personal Author:
    Nguyen, Huong T.T.; Tran, Cuc H.; Dang, Anh D.; Tran, Huong G.T.; Vu, Thiem D.; Pham, Thach N.; Nguyen, Hoang V.; Nguyen, Anh N.K.; Pieracci, Emily G.; Tran, Duong N.;
    Published Date:
    Mar 02 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(8):250-252.
    Description:
    Human rabies deaths are preventable through prompt administration of postexposure prophylaxis (PEP) with rabies immune globulin and rabies vaccine after exposure to a rabid animal (1); there are no known contraindications to receiving PEP (1,2). Desp...
    File Type:
    Filetype[PDF - 115.45 KB]
  5. Filetype[PDF - 23.29 KB]
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    6/20/08
    Series:
    HAN ; 276
    Description:
    Friday, June 20, 2008, 14:30 EDT (2:30 PM EDT)CDCHAN-00276-2008-06-20-ADV-NThe Centers for Disease Control and Prevention (CDC) has been notified that Novartis Vaccines, maker of RabAvert (Rabies Vaccine), will temporarily cease to provide their rabi...
    File Type:
    Filetype[PDF - 23.29 KB]